Science

The extract helped improve lameness scores and inflammatory biomarkers in horses.

Clinical trials design best practices for nutraceuticals

The studies did not find a reduction in COVID-19 incidence after vitamin D supplementation, but a successful vaccination rollout may have impacted the results of the study.

The average time to achieve maximum levels in plasma following supplementation with the sustained release tablet was about 4.5 hours compared to the two to three hours seen in immediate-release formulations.

The study found that subjects with mild to moderate seborrhea of the scalp saw a significant 58.8.% reduction in erythema scores and a substantial 30% decrease in scaling scores after 28 days of using a 5% B’utyQuin Scalp Serum.

Dubbed the VETA Trial (Vitamin D, K2 plus Empagliflozin combination in Type Two Diabetes Mellitus), the six-month prospective, randomized, controlled, open-label, multicenter trial will be conducted in collaboration with the University of Health Sciences Lahore (Pakistan) and the Pakistan Society of Internal Medicine.

Stiriti Ingredients LLC has announced its official entry into the North American dietary supplement, function food and beverage market with its signature SA3X Spilanthes acmella ingredient.

The CRN Foundation has published a new economic report which analyzes the potential healthcare cost savings that could be realized if at-risk populations used specific dietary supplements as a form of preventative healthcare.

Two animal models demonstrated attenuation of eosinophilic activity that is relevant to diseases such as asthma.

Is there any real value in combining mushrooms in a blended product, or is it just “marketing science”?

The synbiotic fiber technology has shown positive preliminary results in supporting metabolic health.

Will new research on quercetin’s immune health properties revitalize interest in the ingredient?

Urox was able to reverse symptoms of overactive bladder induced in rats.

This newly discovered endocannabinoid may have far-reaching health benefits and offers greater insights into the way pentadecanoic acid (C15:0) impacts our overall health.

According to recent study, delta-tocotrienol from annatto decreased biomarkers associated with fatty liver disease in patients diagnosed with non-alcoholic fatty liver disease.

Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.

The new Laboratory Guidance Document provides an evaluation of 46 analytical methods and their suitability to authenticate Boswellia serrata oleogum resin and its extracts.

It’s no wonder that the botanical industry has fixated on fears of adulteration in these challenging times.

A newly published study found that squalene lowered proteinuria, one of the key markers for renal disease, in type 2 diabetes patients.

With elderberry’s fortunes rising along with the research, can we expect its good luck to continue?

The research was a collaboration of university researchers and Morinaga Milk Industry, a leading dairy product company in Japan.

A recent animal study found that fermentation with shiitake mushroom mycelium may result in improvements in digestibility, nutritional value, physical properties, and organoleptic characteristics of pea and rice protein.

ODS supports research and research training on dietary supplements at NIH Institutes, Centers, and Offices.

Kelai Pharmaceutical’s goal is to identify drug candidates in botanical plants to develop pharmaceuticals.

In addition to their ongoing goal of conducting in-depth consumer research, the two companies are launching the second phase of a joint clinical trial known as “Project Happy.”